GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Minerva Surgical Inc (OTCPK:UTRS) » Definitions » Price-to-Free-Cash-Flow

Minerva Surgical (Minerva Surgical) Price-to-Free-Cash-Flow : N/A (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Minerva Surgical Price-to-Free-Cash-Flow?

As of today (2024-05-24), Minerva Surgical's share price is $0.001. Minerva Surgical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-14.02. Hence, Minerva Surgical's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Minerva Surgical's Price-to-Free-Cash-Flow or its related term are showing as below:

UTRS's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.705
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Minerva Surgical's Free Cash Flow per Share for the three months ended in Sep. 2023 was $-0.58. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-14.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -4.70% per year.

During the past 4 years, Minerva Surgical's highest 3-Year average Free Cash Flow per Share Growth Rate was -4.70% per year. The lowest was -4.70% per year. And the median was -4.70% per year.


Minerva Surgical Price-to-Free-Cash-Flow Historical Data

The historical data trend for Minerva Surgical's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minerva Surgical Price-to-Free-Cash-Flow Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
- - - -

Minerva Surgical Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Minerva Surgical's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Minerva Surgical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minerva Surgical's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Minerva Surgical's Price-to-Free-Cash-Flow falls into.



Minerva Surgical Price-to-Free-Cash-Flow Calculation

Minerva Surgical's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.001/-14.015
=N/A

Minerva Surgical's Share Price of today is $0.001.
Minerva Surgical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Minerva Surgical  (OTCPK:UTRS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Minerva Surgical Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Minerva Surgical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Minerva Surgical (Minerva Surgical) Business Description

Traded in Other Exchanges
N/A
Address
4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.
Executives
Daniel Cohen director C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131
Accelmed Partners Ii L.p. 10 percent owner 2875 NE 191ST, SUITE 500, AVENTURA FL 33180
New Enterprise Associates 13 Lp 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Uri Geiger director, 10 percent owner 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Todd Usen director, officer: Chief Executive Officer C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054
Derrick Sung director C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103
David M Clapper director, officer: President and CEO 3003 TASMAN DRIVE, SANTA CLARA CA 95054
Novo Holdings A/s 10 percent owner TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Jaffe Ross A Md director ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Evgueni V. Skalnyi officer: VP Medical Affairs C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Dominique J. Filloux officer: COO C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Joel R Jung officer: CFO 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Niquette L. Hunt director SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Nea Partners 13, Limited Partnership 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202

Minerva Surgical (Minerva Surgical) Headlines

From GuruFocus

Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference

By Stock market mentor Stock market mentor 01-03-2023

Minerva Surgical Announces Time To Talk Campaign

By PurpleRose PurpleRose 08-03-2022

Minerva Surgical to Announce First Quarter 2023 Financial Results

By sperokesalga sperokesalga 04-18-2023

Top 5 1st Quarter Trades of Versant Venture Management, LLC

By GuruFocus Research GuruFocus Editor 05-11-2022

Minerva Surgical to Announce Third Quarter 2022 Financial Results

By Value_Insider Value_Insider 10-26-2022

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-19-2022

Minerva Surgical to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-09-2022

Minerva Surgical Closes $30 Million Private Placement of Common Stock

By sperokesalga sperokesalga 02-09-2023